IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-α production in macrophages

被引:172
作者
Kuwata, H
Watanabe, Y
Miyoshi, H
Yamamoto, M
Kaisho, T
Takeda, K
Akira, S
机构
[1] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan
[2] Japan Sci & Technol Corp, ERATO, Suita, Osaka, Japan
[3] RIKEN Tsukuba Inst, BioResource Ctr, Subteam Manipulat Cell Fate, Tsukuba, Ibaraki, Japan
[4] RIKEN, Res Ctr Allergy & Immunol, Kanagawa, Japan
关键词
D O I
10.1182/blood-2003-04-1228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-10 (IL-10) plays an important role in prevention of chronic inflammation in vivo. However, the molecular mechanism by which IL-10 exerts its anti-inflammatory response is poorly understood. Here, we performed a microarray analysis and identified Bcl-3 as an IL-10-inducible gene in macrophages. Lentiviral vector-mediated expression of Bcl-3 inhibited lipopolysaccharide (LPS)induced production of tumor necrosis factor alpha (TNF-alpha), but not IL-6, in macro-phages. In Bcl-3-transduced and IL-10-pretreated macrophages, LPS-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) p65 was not impaired. However, DNA binding by NF-kappaB p50/065 was profoundly inhibited. Nuclear localization of Bcl-3 was associated with inhibition of LPS-induced TNF-alpha production. Overexpression of Bcl-3 suppressed activation of the TNF-alpha promoter, but not the IL-6 promoter. Bcl-3 interacted With NF-kappaB p50 and was recruited to the TNF-alpha promoter, but not the IL-6 promoter, indicating that Bcl-3 facilitates p50-mediated inhibition of TNF-alpha expression. Furthermore, Bcl-3-deficient macrophages showed defective IL-10-mediated suppression of LPS induction of TNF-alpha, but not IL-6. These findings suggest that IL-10-induced Bcl-3 is required for suppression of TNF-alpha production in macrophages. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:4123 / 4129
页数:7
相关论文
共 45 条
[1]  
Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936
[2]  
BERGERON AL, 2001, BLOOD, V98, P1010
[3]   Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation [J].
Berlato, C ;
Cassatella, MA ;
Kinjyo, I ;
Gatto, L ;
Yoshimura, A ;
Bazzoni, F .
JOURNAL OF IMMUNOLOGY, 2002, 168 (12) :6404-6411
[4]  
BOGDAN C, 1992, J BIOL CHEM, V267, P23301
[5]   THE ONCOPROTEIN BCL-3 DIRECTLY TRANSACTIVATES THROUGH KAPPA-B MOTIFS VIA ASSOCIATION WITH DNA-BINDING P50B HOMODIMERS [J].
BOURS, V ;
FRANZOSO, G ;
AZARENKO, V ;
PARK, S ;
KANNO, T ;
BROWN, K ;
SIEBENLIST, U .
CELL, 1993, 72 (05) :729-739
[6]   NF-κB-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-κB1 residence [J].
Brasier, AR ;
Lu, MP ;
Hai, T ;
Lu, Y ;
Boldogh, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :32080-32093
[7]   Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: Evidence for an IL-10-induced pathway that is independent of STAT protein activation [J].
Cassatella, MA ;
Gasperini, S ;
Bovolenta, C ;
Calzetti, F ;
Vollebregt, M ;
Scapini, P ;
Marchi, M ;
Suzuki, R ;
Suzuki, A ;
Yoshimura, A .
BLOOD, 1999, 94 (08) :2880-2889
[8]  
DONNELLY RP, 1995, J IMMUNOL, V155, P1420
[9]   Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease [J].
Fedorak, RN ;
Gangl, A ;
Elson, CO ;
Rutgeerts, P ;
Schreiber, S ;
Wild, G ;
Hanauer, SB ;
Kilian, A ;
Cohard, M ;
LeBeaut, A ;
Feagan, B .
GASTROENTEROLOGY, 2000, 119 (06) :1473-1482
[10]   Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions [J].
Franzoso, G ;
Carlson, L ;
SchartonKersten, T ;
Shores, EW ;
Epstein, S ;
Grinberg, A ;
Tran, T ;
Shacter, E ;
Leonardi, A ;
Anver, M ;
Love, P ;
Sher, A ;
Siebenlist, U .
IMMUNITY, 1997, 6 (04) :479-490